Literature DB >> 1327427

Feline leukemia virus: pathogenesis of neoplastic disease.

L J Rezanka1, J L Rojko, J C Neil.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1327427     DOI： 10.3109/07357909209024796

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  18 in total

1.  The frequency of occurrence and nature of recombinant feline leukemia viruses in the induction of multicentric lymphoma by infection of the domestic cat with FeLV-945.

Authors:  Shamim Ahmad; Laura S Levy
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

2.  Identification of monoclonal antibodies for immunohistochemical staining of feline B lymphocytes in frozen and formalin-fixed paraffin-embedded tissues.

Authors:  C E Monteith; B J Chelack; W C Davis; D M Haines
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

3.  Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum.

Authors:  Chandtip Chandhasin; Patricia N Coan; Laura S Levy
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.

Authors:  J Pantginis; R M Beaty; L S Levy; J Lenz
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  The surface glycoprotein of a natural feline leukemia virus subgroup A variant, FeLV-945, as a determinant of disease outcome.

Authors:  Lisa L Bolin; Shamim Ahmad; Laura S Levy
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

6.  The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat.

Authors:  Lisa L Bolin; Shamim Ahmad; Patricia A Lobelle-Rich; Tara G Ooms; Xavier Alvarez-Hernandez; Peter J Didier; Laura S Levy
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

7.  Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.

Authors:  Chandtip Chandhasin; Patricia N Coan; Ivona Pandrea; Chris K Grant; Patricia A Lobelle-Rich; Adriane Puetter; Laura S Levy
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

8.  Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.

Authors:  C R Starkey; P A Lobelle-Rich; S W Granger; S Granger; B K Brightman; H Fan; L S Levy
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

9.  Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.

Authors:  Chassidy Johnson; Patricia A Lobelle-Rich; Adriane Puetter; Laura S Levy
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 10.  Advances in understanding molecular determinants in FeLV pathology.

Authors:  Laura S Levy
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.